---
layout: post
title: "Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market"
date: 2026-02-20T11:00:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-announces-1-million-strategic-financing-at-premium-to-market-302693473.html
significance: 9.00
---

<p>NEW YORK, Feb. 20, 2026 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced it has entered into a definitive agreement for a strategic private placement of $1 million. The...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-announces-1-million-strategic-financing-at-premium-to-market-302693473.html)

**Published:** 2026-02-20 11:00:00 +0000

**Significance Score:** 9.00

[View original](https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-announces-1-million-strategic-financing-at-premium-to-market-302693473.html)
